docetaxel anhydrous and choline
docetaxel anhydrous has been researched along with choline in 10 studies
Compound Research Comparison
Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (choline) | Trials (choline) | Recent Studies (post-2010) (choline) |
---|---|---|---|---|---|
12,110 | 3,216 | 6,920 | 19,628 | 608 | 4,345 |
Protein Interaction Comparison
Protein | Taxonomy | docetaxel anhydrous (IC50) | choline (IC50) |
---|---|---|---|
Sodium- and chloride-dependent creatine transporter 1 | Rattus norvegicus (Norway rat) | 1.6 | |
High affinity choline transporter 1 | Mus musculus (house mouse) | 1.6 |
Research
Studies (10)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (20.00) | 29.6817 |
2010's | 7 (70.00) | 24.3611 |
2020's | 1 (10.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Baggett, B; Carroll, D; Day, S; Gillies, RJ; Gray, H; Job, C; Morse, DL; Murthi, S; Raghunand, N; Sadarangani, P | 1 |
Holzapfel, K; Krause, BJ; Müller, SA; Seidl, C; Senekowitsch-Schmidtke, R; Treiber, U | 1 |
Buck, AK; Herrmann, K; Krause, BJ; Nawroth, R; Schuster, T; Schwaiger, M; Senekowitsch-Schmidtke, R; Souvatzoglou, M; Treiber, U; Weber, AW; Weirich, G; Wester, HJ; Ziegler, SI | 1 |
Cheng, I; Kwee, S; Loo, L; Song, MA; Tiirikainen, M | 1 |
Krause, BJ; Nawroth, R; Sachs, D; Schuster, T; Schwaiger, M; Schwarzenböck, S; Senekowitsch-Schmidtke, R; Souvatzoglou, M; Treiber, U; Weirich, G; Wester, HJ; Ziegler, S | 1 |
Bijnsdorp, IV; Geldof, AA; Hoekstra, OS; Oprea-Lager, DE; van de Ven, PM; van den Eertwegh, AJ; van Kanten, MP; van Moorselaar, RJ | 1 |
Bathen, TF; Buckle, T; Heerschap, A; Rottenberg, S; van Asten, JJ; van Leeuwen, F; Vettukattil, R | 1 |
Ardizzoni, A; Borghesi, M; Brunocilla, E; Castellucci, P; Ceci, F; Di Tullio, P; Fanti, S; Graziani, T; Renzi, R; Schiavina, R | 1 |
Burgio, SL; Caroli, P; Casadio, V; Conteduca, V; De Giorgi, U; Gurioli, G; Lolli, C; Matteucci, F; Menna, C; Paganelli, G; Salvi, S; Scarpi, E; Schepisi, G; Testoni, S | 1 |
Ahmed, ME; Alamiri, J; Andrews, JR; Bold, MS; Britton, CJ; Dundar, A; Higa, JL; Karnes, RJ; Kendi, AT; Kwon, E; Lowe, VJ; Pagliaro, LC | 1 |
Other Studies
10 other study(ies) available for docetaxel anhydrous and choline
Article | Year |
---|---|
Characterization of breast cancers and therapy response by MRS and quantitative gene expression profiling in the choline pathway.
Topics: Animals; Cell Extracts; Cell Line, Tumor; Choline; Docetaxel; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genes, Neoplasm; Humans; Magnetic Resonance Spectroscopy; Mammary Neoplasms, Animal; Metabolic Networks and Pathways; Mice; Mice, SCID; Phenotype; Phosphatidylcholines; RNA, Messenger; Taxoids; Xenograft Model Antitumor Assays | 2009 |
Characterization of choline uptake in prostate cancer cells following bicalutamide and docetaxel treatment.
Topics: Androgen Antagonists; Anilides; Antineoplastic Agents; Biological Transport; Cell Line, Tumor; Choline; Diffusion; Docetaxel; Hemicholinium 3; Humans; Male; Nitriles; Organic Cation Transport Proteins; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Taxoids; Tosyl Compounds; Tritium | 2009 |
[11C]Choline as pharmacodynamic marker for therapy response assessment in a prostate cancer xenograft model.
Topics: Animals; Biomarkers, Tumor; Carbon Radioisotopes; Cell Line, Tumor; Choline; Docetaxel; Humans; Male; Mice; Positron-Emission Tomography; Prostatic Neoplasms; Taxoids; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden; Xenograft Model Antitumor Assays | 2010 |
Measurement of circulating cell-free DNA in relation to 18F-fluorocholine PET/CT imaging in chemotherapy-treated advanced prostate cancer.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Choline; DNA Methylation; DNA, Neoplasm; Docetaxel; Electrophoresis, Microchip; Genetic Markers; Glutathione S-Transferase pi; Hawaii; Humans; Male; Middle Aged; Multimodal Imaging; Pilot Projects; Positron-Emission Tomography; Predictive Value of Tests; Promoter Regions, Genetic; Prostatic Neoplasms; Radiopharmaceuticals; Real-Time Polymerase Chain Reaction; Receptors, Retinoic Acid; Taxoids; Tomography, X-Ray Computed; Treatment Outcome; Whole Body Imaging | 2012 |
[[¹¹C]choline as a pharmacodynamic marker for docetaxel therapy. Response assessment in a LNCaP prostate cancer xenograft mouse model].
Topics: Animals; Antineoplastic Agents; Carbon Radioisotopes; Cell Line, Tumor; Choline; Docetaxel; Male; Mice; Mice, SCID; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Taxoids; Treatment Outcome | 2013 |
[18F]fluoromethylcholine as a chemotherapy response read-out in prostate cancer cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Choline; Docetaxel; Drug Screening Assays, Antitumor; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Inhibitory Concentration 50; Male; Prostatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Rhodamines; Taxoids | 2015 |
Increased levels of choline metabolites are an early marker of docetaxel treatment response in BRCA1-mutated mouse mammary tumors: an assessment by ex vivo proton magnetic resonance spectroscopy.
Topics: Animals; Antineoplastic Agents, Phytogenic; Biomarkers, Tumor; Choline; Docetaxel; Genes, BRCA1; Mammary Neoplasms, Animal; Mice; Mutation; Proton Magnetic Resonance Spectroscopy; Taxoids | 2015 |
(11)C-Choline PET/CT in castration-resistant prostate cancer patients treated with docetaxel.
Topics: Aged; Aged, 80 and over; Carbon Radioisotopes; Choline; Docetaxel; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Taxoids; Tomography, X-Ray Computed; Treatment Outcome | 2016 |
Circulating androgen receptor combined with 18F-fluorocholine PET/CT metabolic activity and outcome to androgen receptor signalling-directed therapies in castration-resistant prostate cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Androstenes; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Biomarkers, Tumor; Chlorine; Choline; Docetaxel; Gene Dosage; Humans; Male; Middle Aged; Nitriles; Phenylthiohydantoin; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms, Castration-Resistant; Receptors, Androgen; Signal Transduction | 2017 |
Radiographic paradoxical response in metastatic castrate-resistant prostate cancer (mCRPC) managed with new generation anti-androgens: a retrospective analysis.
Topics: Androgen Antagonists; Choline; Disease Progression; Docetaxel; Humans; Male; Positron Emission Tomography Computed Tomography; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Radiopharmaceuticals; Retrospective Studies; Treatment Outcome | 2022 |